Resources | NITAG RESOURCE CENTER

2023 ∙ Haute Autorité de Santé

Vaccination strategy against pneumococcal infections - Place of pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed) in adults

2023

Pneumococcal vaccination of children in the netherlands

2023

Pneumococcal vaccination of the elderly in the netherlands

2023 ∙ NACI

Recommendations on the use of conjugate pneumococcal vaccine – 15 valent (PNEU-C-15) and 20 valent (PNEU-C-20) in adults: Economic evidence supplementary appendix

2023 ∙ NACI

Public health level recommendations on the use of pneumococcal vaccines in adults, including the use of 15-valent and 20-valent conjugate vaccines

2023 ∙ NACI

Interim guidance on the use of pneumococcal 15-valent conjugate vaccine (PNEU-C-15) in pediatric populations

2023 ∙ Conseil Supérieur de la Santé (CSS)

Pneumococcal vaccination in children and adolescents in Belgium

2022 ∙ Nor, S. F. S. Aminuddin, N. A. Ahmad, N. Hassan, M. R. Nawi, A. M. Ahmad, N. Pang, N. T. P. Omar, A. Madrim, M. F. Mokti, K. Ramdzan, A. R. Rahim, S. S. S. A. Jeffree, M. S.

A Systematic Review and Meta-Analysis of Mobile Phone Messaging Intervention on Vaccine Preventable Diseases

2022 ∙ Mungall, B. A. Hoet, B. Nieto Guevara, J. Soumahoro, L.

A systematic review of invasive pneumococcal disease vaccine failures and breakthrough with higher-valency pneumococcal conjugate vaccines in children

2022 ∙ Parmar, K. Subramanyam, S. Del Rio-Pertuz, G. Sethi, P. Argueta-Sosa, E.

Cardiac Adverse Events after Vaccination—A Systematic Review